These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25131919)

  • 1. Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects.
    Tsoi KK; Wong MC; Tam WW; Hirai HW; Lao XQ; Wang HH; Kwan MW; Cheung CS; Tong EL; Cheung NT; Yan BP; Meng HM; Griffiths SM
    Int J Cardiol; 2014 Oct; 176(3):703-9. PubMed ID: 25131919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: A cohort study.
    Wong MC; Chan DK; Wang HH; Tam WW; Cheung CS; Yan BP; Coats AJ
    Int J Cardiol; 2016 Sep; 219():410-6. PubMed ID: 27362832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of perindopril vs. lisinopril on reducing the incidence of diabetes and renal diseases: A cohort study of 20,252 patients.
    Wong MC; Tam WW; Wang HH; Zhang D; Cheung CS; Yan BP; Leeder SR; Griffiths SM
    Int J Cardiol; 2015; 190():384-8. PubMed ID: 25967701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    Pharmacogenet Genomics; 2009 Jun; 19(6):415-21. PubMed ID: 19352213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.
    Ogilvie RI; Anand S; Roy P; De Souza S;
    Clin Drug Investig; 2008; 28(11):673-86. PubMed ID: 18840010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
    Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
    JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
    Cressman AM; Macdonald EM; Fernandes KA; Gomes T; Paterson JM; Mamdani MM; Juurlink DN;
    Br J Clin Pharmacol; 2015 Oct; 80(4):662-9. PubMed ID: 25980448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites.
    Ogedegbe G; Shah NR; Phillips C; Goldfeld K; Roy J; Guo Y; Gyamfi J; Torgersen C; Capponi L; Bangalore S
    J Am Coll Cardiol; 2015 Sep; 66(11):1224-1233. PubMed ID: 26361152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.
    Brugts JJ; Bertrand M; Remme W; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML; Boersma E
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):391-400. PubMed ID: 28856537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.
    Ionescu DD;
    Clin Drug Investig; 2009; 29(12):767-76. PubMed ID: 19888783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of mortality among Chinese hypertensive patients in Hong Kong: a cohort study.
    Jiang JY; Wong MC; Zhang XH; Fung H; Griffiths S; Mercer S
    J Hum Hypertens; 2009 Nov; 23(11):735-42. PubMed ID: 19339999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of cancer deaths among hypertensive patients in a large Chinese population: a cohort study.
    Wong MC; Tam WW; Lao XQ; Wang HH; Kwan MW; Cheung CS; Tong EL; Cheung NT; Griffiths SM; Coats AJ
    Int J Cardiol; 2015 Jan; 179():178-85. PubMed ID: 25464439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.
    Weir MA; Fleet JL; Dixon SN; Jain AK; Oliver M; Wald R; McIntyre C; Garg AX
    Blood Purif; 2015; 40(3):232-42. PubMed ID: 26382240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
    Dinicolantonio JJ; Lavie CJ; O'Keefe JH
    Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Leenen FH; Nwachuku CE; Black HR; Cushman WC; Davis BR; Simpson LM; Alderman MH; Atlas SA; Basile JN; Cuyjet AB; Dart R; Felicetta JV; Grimm RH; Haywood LJ; Jafri SZ; Proschan MA; Thadani U; Whelton PK; Wright JT;
    Hypertension; 2006 Sep; 48(3):374-84. PubMed ID: 16864749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors and cough.
    Yeşil S; Yeşil M; Bayata S; Postaci N
    Angiology; 1994 Sep; 45(9):805-8. PubMed ID: 8092546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: a cohort study.
    Wong MC; Tam WW; Lao XQ; Wang HH; Kwan MW; Cheung CS; Tong EL; Cheung NT; Yan BP; Yu CM; Griffiths SM
    Int J Cardiol; 2014 Aug; 175(3):425-32. PubMed ID: 24986230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.